首页 正文

A comparison of methods for enriching network meta-analyses in the absence of individual patient data

{{output}}
During drug development, a biomarker is sometimes identified as separating a patient population into those with more and those with less benefit from evaluated treatments. Consequently, later studies might be targeted, while earlier ones are performed in mixed... ...